TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT00927979

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10 mLRopivacaine 1%
Description: Intraperitoneal nebulization of 10 mL Ropivacaine 1%

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Water for injection
Description: Intraperitoneal nebulization of 10 mL water for injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10 mL Ropivacaine 1%
Description: Intraperitoneal nebulization of 10 mL Ropivacaine 1%
Study: NCT01552629

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QGE031

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclosporine A
Study: NCT00990093

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: test intermittent catheter
Description: CH 12 hydrophilic coated catheter

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent catheterization
Description: CH 12 hydrophilic catheter
Study: NCT01093365

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Varenicline
Description: * 0.0 mg orally twice per day for three days (placebo)~* 0.5 mg orally twice per day for three days~* 1.0 mg orally twice per day for three days
Study: NCT03125915

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Communication skills training video
Description: This video includes 4 scenes of gay couples discussing issues related to HIV prevention, testing, sexual agreements, and drug use. Each scene is viewed twice. The first viewing includes common communication errors. The second viewing portrays more skillful interpersonal communication and a more adaptive resolution to the conversation.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Communication skills training video
Description: This video includes 4 scenes of gay couples discussing issues related to HIV prevention, testing, sexual agreements, and drug use. Each scene is viewed twice. The first viewing includes common communication errors. The second viewing portrays more skillful interpersonal communication and a more adaptive resolution to the conversation.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: substance use module
Description: This activity involves completion of a calendar detailing partners' substance use in the past month and a structured debriefing activity designed to facilitate the formation of couples' goals and limits around substance use.
Study: NCT01854554

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Questionnaires about quality of life and symptoms given at baseline, 4 months, then every 2 months for 2 years.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Questionnaires about quality of life and symptoms given at baseline, 4 months, then every 2 months for 2 years.
Study: NCT03881462

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Axillary nerve block for artificial deltoid muscle palsy
Description: Axillary nerve block block (AXNB):~The ultrasound probe is placed transversally in the infraclavicular region with the arm in 90° abduction. The brachial plexus and its cords are identified l lateral to the brachial artery. The posterior cord is identified by ultrasound and is blocked - or, if the axillary nerve visible too - the axillary nerve is selectively blocked when it leaves the posterior cord and lies on the subscapular muscle accompanied by the posterior circumflex humeral artery. Using an in-plane technique, a short bevel connected to a nerve stimulator with the setting 0.5 mA current intensity, 0.1 ms impulse duration and 2 Hz impulse frequency for dual guidance, will be advanced until its tip is positioned near the nerve without eliciting motor contractions. After careful negative (for blood) aspiration local anesthetic will be applied until the targeted neuronal structure is surrounded by the injected fluid.
Study: NCT01658683

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise Facilitator Intervention
Description: The 50 week intervention includes 5 small group counseling teleconferences, 3 personal telephone calls and Heart Wise Exercise program demonstrations. During the teleconferences and personal telephone calls, the facilitator discusses the importance of exercise. Participants review their activity diaries, identify barriers to exercise maintenance experienced to date and brainstorm solutions as a group. In addition, the facilitator conducts community program demonstrations at Heart Wise Exercise program locations in Ottawa and Toronto for interested participants.
Study: NCT03736200

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exergaming group
Description: Neurorehabilitation - 4-week-long intervention, targeted postural instability and mobility using at-limit intensity sensori and visuomotor agility training. (1/day)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physiotherapy
Description: Physiotherapy 4-week-long.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exergaming group 2/day
Description: Neurorehabilitation - 4-week-long intervention, targeted postural instability and mobility using at-limit intensity sensori and visuomotor agility training. (2/day)
Study: NCT04718246

Intervention type: OTHER
Group type: OTHER
Intervention: Dental Implants Placed In hyperlipidemia patients
Description: A preoperative cone beam CT (CBCT) will be performed for each patient prior to the surgery.~Surgical phase (T0):~After local anesthetics, all osteotomies will be prepared by the same operator, using a drilling speed of 1200 rpm, under copious irrigation with normal saline.~* Penetration of cortical bone will be achieved with no. 6 round burs.~* The osteotomies will be widened, using a drill 1 mm larger than the final drill provided by the manufacturer. The final size of the control osteotomies were same diameter of the implant.~* Periotest® will measure initial implant stability. Implant site exposure will take place 6 months following the implant placement. Insertion of the healing collars in order to obtain adequate soft tissue form for 1-2 weeks
Study: NCT04020731

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hypnosis
Description: several blocks of hypnosis including entry into a hypnotic state (= induction), the hypnotic trance and the exit from hypnosis (= reassociation).
Study: NCT03297879

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Exenatide or metformin hydrochloride
Description: Exenatide was administrated with 5 μg bid for 4 weeks and 10 μg bid for 8 weeks. Metformin hydrochloride was initiated at a dose of 500 mg bid for 2 weeks, and added to 2.0 g/day for 8 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Exenatide or metformin hydrochloride
Description: Exenatide was administrated with 5 μg bid for 4 weeks and 10 μg bid for 8 weeks. Metformin hydrochloride was initiated at a dose of 500 mg bid for 2 weeks, and added to 2.0 g/day for 8 weeks.
Study: NCT03868904

Intervention type: DEVICE
Intervention: OCS Lung System
Description: No active interventions are part of this study. This study will collect long-term survival and BOS data in subjects who were part of the INSPIRE trial.
Study: NCT03125915

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: substance use module
Description: This activity involves completion of a calendar detailing partners' substance use in the past month and a structured debriefing activity designed to facilitate the formation of couples' goals and limits around substance use.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Couples HIV Testing and Counseling
Description: CHTC delivered as per the CDC protocol.
Study: NCT00934193

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gabapentin
Description: Treatment will consist of a 600 mg dose of gabapentin or placebo given preoperatively the night before surgery, based on a computer generated randomized assignment. The treatment group will continue to be medicated with gabapentin 300 mg twice daily for one month following surgery. Those not included in the treatment arm of the study will continue to take a placebo for the same duration. Follow-up will consist of a postoperative visit at approximately 48 hours and a one month clinical visit.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Treatment will consist of a 600 mg dose of gabapentin or placebo given preoperatively the night before surgery, based on a computer generated randomized assignment. The treatment group will continue to be medicated with gabapentin 300 mg twice daily for one month following surgery. Those not included in the treatment arm of the study will continue to take a placebo for the same duration. Follow-up will consist of a postoperative visit at approximately 48 hours and a one month clinical visit.
Study: NCT03751904

Intervention type: DEVICE
Group type: OTHER
Intervention: AcoustiCare
Description: Electronic stethoscope
Study: NCT04410432

Intervention type: BIOLOGICAL
Intervention: Blood sample collection
Description: Additional blood volumes taken during a routine care blood test:~* 1 dry tube 5 mL for isolation and freezing of serum~* 1 x 5 mL EDTA tube to isolate and freeze plasma~* 8 heparinized 6 mL tubes for flow cytometry study
Study: NCT00572572

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aprepitant
Description: Subjects will be randomized to receive aprepitant 125mg PO day 3 then 80mg on days 4-7 on either cycle 1 or cycle 2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aprepitant
Description: Subjects will be randomized to receive aprepitant 125mg PO day 3 then 80mg on days 4-7 on either cycle 1 or cycle 2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subjects will be randomized to receive placebo on days 3-7 on either cycle 1 or cycle 2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subjects will be randomized to receive placebo on days 3-7 on either cycle 1 or cycle 2.
Study: NCT02894645

Intervention type: DRUG
Group type: OTHER
Intervention: Methotrexate
Description: Intrathecal/ Intravenous/ Oral
Study: NCT00958919

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: naloxone
Description: 10 mg naloxone in 25 ml total volume

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: 25 ml
Study: NCT01573702

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Stereotactic Radiosurgery
Description: 21 Gy daily for 5 days

Intervention type: DRUG
Group type: OTHER
Intervention: Erlotinib
Description: 150mg once daily
Study: NCT03142074

Intervention type: OTHER
Intervention: Biomechanical and microstructural analysis of ATAA
Description: Tissue collection; microstructural testing of tissue; mechanical testing of tissue .

Intervention type: RADIATION
Intervention: ECG-gated CT
Description: Image analysis of ECG-gated CT.
Study: NCT02390804

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: single-port laparoscopic hysterectomy(single port trochar)
Description: perform laparoscopic hysterectomy via single-port access

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: multi-port laparoscopic hysterectomy(multi port trochar)
Description: perform laparoscopic hysterectomy via multi-port access
Study: NCT03883672

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Personality and transactional factors
Description: 1. Pre-admission transplant questionnaire: given and collected by the transplant physician during the pre-graft consultation before entering hospitalization (approximatively 15 days before). To be completed by the patient on site (approximately 45 minutes to complete the questionnaire)~2. Transplant admission questionnaire: given during the first days of hospitalization. To be completed within 6 days and returned to the transplant physician (approximately 30 minutes to complete the questionnaire)~3. Post-transplant follow-up questionnaire: given in consultation at 6 months by the transplant physician (between 30 and 45 minutes to complete the questionnaire in consultation)
Study: NCT01231711

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vets Prevail
Description: The intervention has two primary components that are both delivered over the Internet:~The first component is a structured series of brief peer-to-peer instant messaging Chats structured around ensuring effective motivation, engagement, and completion. This component was modeled after Motivational Interviewing (MI) techniques. The peer-to-peer contact was provided by a master's level social worker, as well as by trained and certified combat veterans who completed the Vet-to-Vet counseling certificate program offered by the Depression and Bipolar Support Alliance (DBSA).~The second component consists of six 30-minute e-Learning Lessons using standard Cognitive Behavioral Therapy (CBT) approaches to reducing depressive and anxiety symptoms and strengthening coping skills.
Study: NCT03936244

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transurethral Resection of the Prostate (TURP)
Description: Randomized allocation to M-TURP or PK-TURP

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transurethral Resection of the Prostate (TURP)
Description: Randomized allocation to M-TURP or PK-TURP
Study: NCT01973790

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Z-338
Description: 100mg TID
Study: NCT00975234

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intra-lesion injection of autologous skeletal myoblasts
Description: Intra-lesion injection

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Revascularisation
Description: Revascularisation surgery

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Revascularisation
Description: Revascularisation surgery
Study: NCT03790982

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of AD-35 60mg /AD-35 30mg
Description: Placebo 60mg, oral, 1st 26 weeks; AD-35 30mg +Placebo of AD-35 30mg oral 2nd 26 weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of AD-35 60mg /AD-35 60mg
Description: Placebo 60mg, oral, 1st 26 weeks; AD-35 60mg oral, 2nd 26 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AD-35 30 mg + Placebo of AD-35 30 mg
Description: AD-35 30 mg + Placebo of AD-35 30 mg AD-35 30 mg + Placebo of AD-35 30 mg, Oral, 52 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AD-35 60 mg
Description: AD-35 60 mg AD-35 30 mg x two tablets, oral, 52 weeks.
Study: NCT01114646

Intervention type: DEVICE
Group type: OTHER
Intervention: Cemented Hip Hemiarthroplasty
Description: The cemented femoral prosthesis is a VerSys LD/Fx, Zimmer, Warsaw, IN.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VerSys Beaded FullCoat, Zimmer
Description: The press-fit component is a VerSys Beaded FullCoat, Zimmer, Warsaw, IN,
Study: NCT04735133

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: pNBYT
Description: pNPWT device (80mm Hg) was placed in the pNPWT group for seven days The incision area was evaluated during the first seven days, and on the 15th, 21st, and 30th days postoperatively for the presence of hematoma, seroma, wound dehiscence/evisceration, and SSI.
Study: NCT01513304

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Manual therapy
Study: NCT03060941

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity education
Description: Participants will be given educational materials on how to increase physical activity levels.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity education
Description: Participants will be given educational materials on how to increase physical activity levels.
Study: NCT03125915

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Couples HIV Testing and Counseling
Description: CHTC delivered as per the CDC protocol.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Couples HIV Testing and Counseling
Description: CHTC delivered as per the CDC protocol.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Couples HIV Testing and Counseling
Description: CHTC delivered as per the CDC protocol.
Study: NCT03147521

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Care bundle
Description: Risk fall assessment at hospital admission with Conley scale or with findings of specific risk characteristics (previous falls, cognitive impairment, neuropsychological damage, increased need to go to the bathroom for increased evacuative needs, neuroleptic or cardiovascular drugs assumption); if risk is found shear the information with the team, writing it in patient chart, and positioning a specific symbol on patient bed. Inform patient and family about fall risk and ask, if possible, a continuous caregiver presence. Universal strategy application for the environmental safety and patient safety. Periodic assessment of drugs therapy, with the aim of reduce those that acts on central nervous system and cardiovascular system. If patient is at risk and alone, verify each 2 hours the need to go to the bathroom, change position or drink.
Study: NCT03060941

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity education
Description: Participants will be given educational materials on how to increase physical activity levels.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity education
Description: Participants will be given educational materials on how to increase physical activity levels.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity education
Description: Participants will be given educational materials on how to increase physical activity levels.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity education
Description: Participants will be given educational materials on how to increase physical activity levels.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity education
Description: Participants will be given educational materials on how to increase physical activity levels.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity education
Description: Participants will be given educational materials on how to increase physical activity levels.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity education
Description: Participants will be given educational materials on how to increase physical activity levels.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity education
Description: Participants will be given educational materials on how to increase physical activity levels.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity education
Description: Participants will be given educational materials on how to increase physical activity levels.
Study: NCT03147521

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Care bundle
Description: Risk fall assessment at hospital admission with Conley scale or with findings of specific risk characteristics (previous falls, cognitive impairment, neuropsychological damage, increased need to go to the bathroom for increased evacuative needs, neuroleptic or cardiovascular drugs assumption); if risk is found shear the information with the team, writing it in patient chart, and positioning a specific symbol on patient bed. Inform patient and family about fall risk and ask, if possible, a continuous caregiver presence. Universal strategy application for the environmental safety and patient safety. Periodic assessment of drugs therapy, with the aim of reduce those that acts on central nervous system and cardiovascular system. If patient is at risk and alone, verify each 2 hours the need to go to the bathroom, change position or drink.
Study: NCT01770639

Intervention type: PROCEDURE
Intervention: MFB
Description: Surgical arthrodesis of the midfoot with the Midfoot Fusion Bolt (MFB)
Study: NCT00488839

Intervention type: DRUG
Group type: OTHER
Intervention: IPX056 20 mg
Description: IPX056 Extended Release capsule containing 20 mg baclofen

Intervention type: DRUG
Group type: OTHER
Intervention: IPX056 20 mg
Description: IPX056 Extended Release capsule containing 20 mg baclofen
Study: NCT03060941

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity education
Description: Participants will be given educational materials on how to increase physical activity levels.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity education
Description: Participants will be given educational materials on how to increase physical activity levels.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity education
Description: Participants will be given educational materials on how to increase physical activity levels.
Study: NCT00488839

Intervention type: DRUG
Group type: OTHER
Intervention: IPX056 20 mg
Description: IPX056 Extended Release capsule containing 20 mg baclofen

Intervention type: DRUG
Group type: OTHER
Intervention: IPX056 20 mg
Description: IPX056 Extended Release capsule containing 20 mg baclofen

Intervention type: DRUG
Group type: OTHER
Intervention: IPX056 40 mg
Description: IPX056 Extended Release capsule containing 40 mg baclofen

Intervention type: DRUG
Group type: OTHER
Intervention: IPX056 40 mg
Description: IPX056 Extended Release capsule containing 40 mg baclofen
Study: NCT03060941

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity education
Description: Participants will be given educational materials on how to increase physical activity levels.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity education
Description: Participants will be given educational materials on how to increase physical activity levels.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Facility access
Description: Participants will receive at 6 month membership to a local fitness facility.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Facility access
Description: Participants will receive at 6 month membership to a local fitness facility.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Facility access
Description: Participants will receive at 6 month membership to a local fitness facility.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Facility access
Description: Participants will receive at 6 month membership to a local fitness facility.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Facility access
Description: Participants will receive at 6 month membership to a local fitness facility.